Logo image of ALBOO.PA

BOOSTHEAT SACA (ALBOO.PA) Stock Fundamental Analysis

EPA:ALBOO - Euronext Paris - Matif - FR001400OS22 - Common Stock - Currency: EUR

0.0054  0 (-15.62%)

Fundamental Rating

1

ALBOO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 104 industry peers in the Machinery industry. ALBOO has a bad profitability rating. Also its financial health evaluation is rather negative. ALBOO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALBOO had negative earnings in the past year.
ALBOO had negative earnings in each of the past 5 years.
ALBOO had a negative operating cash flow in each of the past 5 years.
ALBOO.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -1426.60%, ALBOO is doing worse than 94.23% of the companies in the same industry.
Industry RankSector Rank
ROA -1426.6%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBOO.PA Yearly ROA, ROE, ROICALBOO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALBOO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALBOO.PA Yearly Profit, Operating, Gross MarginsALBOO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K

More info and screens

0

2. Health

2.1 Basic Checks

ALBOO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALBOO.PA Yearly Shares OutstandingALBOO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
ALBOO.PA Yearly Total Debt VS Total AssetsALBOO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M

2.2 Solvency

ALBOO has an Altman-Z score of -24.61. This is a bad value and indicates that ALBOO is not financially healthy and even has some risk of bankruptcy.
ALBOO has a worse Altman-Z score (-24.61) than 81.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -24.61
ROIC/WACCN/A
WACCN/A
ALBOO.PA Yearly LT Debt VS Equity VS FCFALBOO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.21 indicates that ALBOO may have some problems paying its short term obligations.
ALBOO has a worse Current ratio (0.21) than 94.23% of its industry peers.
A Quick Ratio of 0.21 indicates that ALBOO may have some problems paying its short term obligations.
With a Quick ratio value of 0.21, ALBOO is not doing good in the industry: 94.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
ALBOO.PA Yearly Current Assets VS Current LiabilitesALBOO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALBOO have decreased strongly by -132324.21% in the last year.
The Revenue has been growing slightly by 7.15% in the past year.
ALBOO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.29% yearly.
EPS 1Y (TTM)-132324.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144715.35%
Revenue 1Y (TTM)7.15%
Revenue growth 3Y26.29%
Revenue growth 5YN/A
Sales Q2Q%115.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBOO.PA Yearly Revenue VS EstimatesALBOO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALBOO.PA Yearly EPS VS EstimatesALBOO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALBOO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBOO.PA Price Earnings VS Forward Price EarningsALBOO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBOO.PA Per share dataALBOO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2M -4M -6M

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBOO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOOSTHEAT SACA

EPA:ALBOO (3/7/2025, 7:00:00 PM)

0.0054

0 (-15.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-25 2024-11-25
Earnings (Next)06-09 2025-06-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.9%
Ins Owner ChangeN/A
Market Cap2.32K
Analysts37.14
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6801347.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.65
BVpS-46.91
TBVpS-46.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1426.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -24.61
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132324.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144715.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.15%
Revenue growth 3Y26.29%
Revenue growth 5YN/A
Sales Q2Q%115.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A